NCT02109302

Brief Summary

The main objective of our study is to identify the first genetic etiology of primary Premature Ejaculation (PE). We will test and evaluate the existence of genetic determinism conferring susceptibility to a life-long syndrome (primary premature ejaculation) in some patients. To this end, we plan to establish a collection of biological samples and a database of patients with this extreme syndrome, which we will analyze by Genome Wide analysis. This will lead to improvements in the biological understanding, the "knowledge" of physicians of the disease, and should improve the patients' quality of life. Not all PE cases have the same physiopathology and treatment efficiency, which depend on the specific mechanism involved in the clinical context. Our work will make it possible to develop new therapeutic approaches suitable for a large proportion of individuals presenting PE. This integrative approach combining researchers, patients and ethics committees will facilitate profound reflection, promoting the creation of suitable structures capable of receiving patients for appropriate consultations. This unique study of PE should also favor industrial partnerships.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2014

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2020

Completed
Last Updated

March 14, 2025

Status Verified

January 1, 2025

Enrollment Period

5.9 years

First QC Date

April 2, 2014

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of subjects with genetic mutations of susceptibility to primary PE

    We will perform WES (Whole Exome Sequencing) to identify shared defective genes in 20 patients. In case of genetic uniformity and of a genetically homogeneous recruitment, we hope to highlight such a gene in several individuals. As primary PE are very rare, this group should have defective genes at much higher frequencies than in the control population (NCBI, 1000 genome and housing-genome). This will allow us to identify genetic mutations of susceptibility to primary PE.

    4 years

Study Arms (1)

Men over 18 years of age with primary Premature Ejaculation

EXPERIMENTAL
Procedure: Blood sampleProcedure: Skin biopsyOther: Questionnaire

Interventions

Blood samplePROCEDURE
Men over 18 years of age with primary Premature Ejaculation
Skin biopsyPROCEDURE
Men over 18 years of age with primary Premature Ejaculation
Men over 18 years of age with primary Premature Ejaculation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients (index cases ) Prospective and retrospective cases
  • Man aged over 18 years
  • signing the informed consent
  • Presenting primary PE
  • have an affiliation to a social security system
  • Related
  • Male or female over 18 years
  • be related to the index case
  • signing the informed consent
  • have an affiliation to a social security system
  • Patients ( index case ) :
  • Be aged under 18
  • have known genetic variations that predispose or can promote psychological disorders that can lead to PE ( eg: Kallman 's Syndrome , micropenis , testicular dysgenesis , Klinfelter syndrome, Leydig cell hypoplasia )
  • have had psycho- social and psycho- traumatic factors in childhood
  • Inability to receive clear information on the protocol
  • +13 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Polyclinique de Blois

La Chaussée-Saint-Victor, 41260, France

Location

Hôpital Saint Joseph

Marseille, 13285, France

Location

Hôpital Necker

Paris, 75015, France

Location

Related Publications (1)

  • Porto R, Giuliano F. [Premature ejaculation]. Prog Urol. 2013 Jul;23(9):647-56. doi: 10.1016/j.purol.2013.01.005. Epub 2013 Mar 1. French.

    PMID: 23830259BACKGROUND

MeSH Terms

Conditions

Premature Ejaculation

Interventions

Blood Specimen CollectionSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Ejaculatory DysfunctionGenital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Alexandre Alcaïs, MD

    Hôpital Necker

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2014

First Posted

April 9, 2014

Study Start

April 1, 2014

Primary Completion

February 11, 2020

Study Completion

February 11, 2020

Last Updated

March 14, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations